The Week in Review: Tigermed, clinical CRO, Plans IPO - FLASH: Pricing set
04:34 EDT 5 Aug 2012 | ChinaBio Today
Tigermed Consulting, the clinical-stage CRO headquartered in Hangzhou, will stage an IPO on the ChiNext exchange, with pricing expected August 6 (UPDATE: pricing to be set at 37.8 RMB/share); Covidien officially opened its China medical device R&am..
Original Article: The Week in Review: Tigermed, clinical CRO, Plans IPO - FLASH: Pricing set
More From BioPortfolio on "The Week in Review: Tigermed, clinical CRO, Plans IPO - FLASH: Pricing set"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
